that is, it becomes metabolically flexible
Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins
From the point of view of clinical relevance, pathophysiological responses to GLP-1 demonstrated in current study including acute increases in RSNA, MAP and HR and decreases in diuresis and natriuresis, all features that are likely to be unfavorable and might contribute to a greater risk for HF
Social determinants of health, systematic and unconscious bias, and healthcare access are all underpinning factors and tough obstacles to overcome
Additionally, ongoing studies suggest that GLP-1 medications may benefit conditions such as non-alcoholic fatty liver disease (NAFLD) and polycystic ovary syndrome (PCOS) by improving insulin sensitivity, reducing inflammation, and positively influencing metabolism